beth israel deaconess medical center a harvard medical school teaching hospital

To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Genitourinary Cancer Program

Multidisciplinary diagnosis and treatment of patients with cancer of the prostate, bladder, testis or kidney.


Leading oncologists, urological surgeons, radiation oncologists, radiologists and pathologists provide state-of-the-art diagnosis and management for genitourinary cancers. Treatment expertise includes:

  • Minimally invasive, nerve-sparing prostatectomy, allowing discharge home within 24 hours.
  • Radioactive seed implant brachytherapy for prostate cancer.
  • Watchful waiting strategies for prostate cancer.
  • Minimally invasive surgical techniques, including partial or laparoscopic nephrectomy for renal cancer.
  • Radiofrequency ablation for renal masses.
  • Bladder-sparing operations and orthotopic diversion for bladder cancer.

The BIDMC Prostate Cancer Center offers a multidisciplinary clinic for diagnosis and treatment of early prostate cancer. Our mission is to effectively treat prostate cancer while optimizing quality of life among prostate cancer patients and their spouses or partners.

The center's clinical expertise includes BIDMC surgeons and radiation oncologists who have performed more than 2,000 surgical prostatectomies or prostate seed implants, and medical oncologists who have pioneered watchful waiting, hormonal and chemotherapy for early and late-stage prostate cancers.

BIDMC is an NCI-designated site of research excellence in renal and prostate cancers through NCI SPORE grants in these diseases. Research expertise in the Prostate Cancer Center includes: evaluating quality of life and treatment satisfaction among prostate cancer patients and their spouses; determining the role of androgen receptor mutations in prostate cancer hormone independence; characterizing novel prostate cancer biomarkers through prospective cohorts; evaluating inhibitors of signal transduction pathways in hormone-independent prostate cancer; and refining chemotherapy and hormonal therapy for newly diagnosed high-risk prostate cancer.

Contact Information

Genitourinary Oncology
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215
617-667-1900

RELATED LINKS